- Home
- News & Events
- In the News
In the News
91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this article,Brian HuberandTamie Joeckel,
-
Rose Kidd, Executive Vice President, Quality and Compliance at 91黑料, discusses how in the area of QA.
This article is taken from International Pharmaceutical Industry, Volume 14, Issue 3, pages 32-33. Senglobal Ltd
-
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. Laney Preheim outlines
This article is taken fromInnovations in Pharmaceutical Technology, October 2022, pages 34-36 . Samedan Ltd
-
This news article, first published on , outlines how 91黑料 has been selected by
-
Using RWE in rare disease drug development: effective innovations with historical controls
With a growing number of therapies under development for rare diseases, William Maier discusses how real-world evidence can be effectively used as a historical control, overcoming challenges presented in clinical development.
-
Robotic Process Automation: Recruiting bots to accelerate clinical trials
Ronan Fox, Senior Vice President of Applied Digital Solutions, contributes his views on the increasing use of RPA in clinical trials.
-
Samir Shah, President, Strategic Solutions at 91黑料 contributes to this Applied Clinical Trials article discussing the in the CRO industry.
Reprinted with permission from Applied Clinical Trials. Applied Clinical Trials is a copyrighted publication of MultiMedia Healthcare, LLC. All rights reserved.
-
Embedding the patient point of view in everything you do
Rachel Ballinger, Patient Centred Outcomes Principal, shares the importance of using positive language when speaking with study participants.
-
Considerations for vaccine efficacy trials targeting emerging infectious diseases
Following the COVID-19 pandemic, Shelley McLendon outlines what lessons must be learned to prevent future other emerging infectious diseases developing on a similar scale.
This article is taken from European Biopharmaceutical Review October 2022, pages 16-18. Samedan Ltd
-
CFO Brendan Brennan outlines .